Institution Directory

Clinical trials at Mount Sinai

Sites in New York, NY

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1097

Shown on this page

Current sort

Live official records

Conditions: Heart Septal Defect, Heart Septal Defects, Atrial, Heart Defects, Congenital, Cardiovascular Abnormalities, Cardiovascular Diseases, Heart Diseases, Congenital Abnormalities
Interventions: reSept ASD Occluder; Device
Lead sponsor: atHeart Medical; Industry
Eligibility: Up to 84 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2032
U.S. locations: 24
States / cities: Birmingham, Alabama • Los Angeles, California • Thousand Oaks, California + 21 more

Conditions: Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8
Interventions: Capecitabine, Fluorouracil, Leucovorin, Leucovorin Calcium, Oxaliplatin, Patient Observation; Drug · Other
Lead sponsor: NRG Oncology; Other
Eligibility: 18 Years and older
Enrollment: 635 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 932
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 639 more

Conditions: Ruptured Cerebral Aneurysm
Interventions: Nautilus Intrasaccular Bridging System; Device
Lead sponsor: EndoStream Medical; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 4
States / cities: Jacksonville, Florida • Tampa, Florida • Buffalo, New York + 1 more

Conditions: Atherosclerotic Cardiovascular Disease
Interventions: Inclisiran; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 30 Years to 50 Years
Enrollment: 1,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2032
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostate Cancer, Erectile Dysfunction
Interventions: RALP (Robotic-assisted radical prostatectomy), SAFE (Saline assisted fascial engorgement); Procedure · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Male only
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Bronchial Stents
Interventions: Bronchoscopy; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Hyperammonemia, Methylmalonic Acidemia, Propionic Acidemia
Interventions: Carglumic Acid; Drug
Lead sponsor: RECORDATI GROUP; Industry
Eligibility: Not listed
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Tampa, Florida • Chicago, Illinois + 2 more

Conditions: Atrial Fibrillation, Atrial Fibrillation, Persistent, Atrial Fibrillation Paroxysmal, Arrhythmia, Arrhythmias, Cardiac, Atrial Flutter, Atrial Fibrillation, Paroxysmal or Persistent, Atrial Arrhythmia, Atrial Tachycardia
Interventions: Electrographic Flow (EGF) mapping and ablation of EGF-identified sources of Atrial Fibrillation, Electrographic Flow (EGF) mapping (no ablation); Device
Lead sponsor: Cortex; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 15
States / cities: Birmingham, Alabama • Phoenix, Arizona • Redwood City, California + 11 more

Conditions: Nasopharyngeal Carcinoma
Interventions: Penpulimab, placebo; Drug
Lead sponsor: Akeso; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 296 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 5
States / cities: Duarte, California • Atlanta, Georgia • Ann Arbor, Michigan + 1 more

Conditions: Cognitive Intervention to Promote Healthy Development of Executive Function (EF) Skills in Young Children
Interventions: Executive Function Intervention; Device
Lead sponsor: Koronis Biomedical Technologies; Industry
Eligibility: 2 Years to 5 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Minneapolis, Minnesota • New York, New York

Conditions: Acute Respiratory Distress Syndrome, Acute Hypoxemic Respiratory Failure, Acute Hypercapnic Respiratory Failure
Interventions: Toning, Ocean drum & SOK melody, SOK, Process, Holding Harmonic Container; Other · Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 3
States / cities: New York, New York • Houston, Texas

Conditions: Hypochondroplasia
Interventions: Not listed
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: Up to 15 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2043
U.S. locations: 16
States / cities: Phoenix, Arizona • Los Angeles, California • Oakland, California + 13 more

About this Mount Sinai institution page

What this page lists: ClinicalTrials.gov records that list Mount Sinai in New York, NY as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Mount Sinai

Filter and sort this campus

Live official records

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

A Medical Device to Treat Wide-Neck Brain Aneurysms

The Prevent Coronary Artery Disease Trial

SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)

Surveillance Versus Bronchoscopy After Airway Stenting

An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Parent-Child EF Intervention

The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

About this Mount Sinai institution page